@dr.yerayraiz's age-specific TRT advice needs context
Quick answer
Testosterone replacement therapy requires evaluation of both low testosterone levels (typically under 300 ng/dL on multiple tests) and clinical symptoms, regardless of patient age. The TRAVERSE trial (2018) demonstrated cardiovascular safety in symptomatic hypogonadal men aged 45-80, but treatment decisions should be individualized rather than age-based.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Dr. Yeray Raíz's Instagram reel appears to solicit ages from US followers, presumably to provide testosterone replacement therapy guidance based on age ranges. The video targets men's health with hashtags suggesting TRT recommendations.
Without seeing the actual video content, the engagement pattern suggests age-based TRT advice. This approach raises questions about whether blanket recommendations by age group align with evidence-based medicine.
The 610,000 views indicate significant reach for what appears to be medical guidance on a complex hormonal therapy.
Does age alone determine TRT candidacy?
Age is just one factor in TRT evaluation, and it's not the most important one. Symptoms matter more than numbers on a birth certificate when determining treatment need.
The American Urological Association guidelines require both low testosterone levels (typically under 300 ng/dL on two separate morning tests) and clinical symptoms like fatigue, decreased libido, or mood changes. Age ranges from 20s to 80s don't automatically qualify or disqualify someone.
Research from Bhasin et al. (NEJM, 2018) in the TRAVERSE trial studied men aged 45-80 with documented hypogonadism. The focus was on cardiovascular safety in symptomatic men with confirmed low T, not age-based prescribing patterns.
What about testosterone's natural decline?
Testosterone does decline with age, but not uniformly or predictably enough for age-based treatment protocols. The Baltimore Longitudinal Study found average decreases of 1-2% annually after age 40.
However, this decline varies wildly between individuals. Some 70-year-old men maintain higher testosterone levels than some 30-year-olds. Total testosterone ranges from 300-1000 ng/dL in healthy adult males regardless of age.
The Massachusetts Male Aging Study showed that obesity and chronic illness affect testosterone more than age alone. A healthy 60-year-old often has higher levels than an overweight 40-year-old.
What are the real TRT considerations?
Proper TRT evaluation requires comprehensive assessment, not age-based shortcuts. Blood work should include total testosterone, free testosterone, LH, FSH, and prolactin levels.
Contraindications include untreated sleep apnea, prostate cancer history, severe heart failure, and uncontrolled polycythemia. These conditions don't correlate with specific age ranges but require individual screening.
The TTrials (Snyder et al., NEJM, 2016) demonstrated benefits in men over 65 with confirmed hypogonadism, including improved sexual function and bone density. But participants were selected based on symptoms and lab values, not age alone.
What should you actually know about TRT timing?
TRT timing depends on individual health status, symptom severity, and lab results rather than chronological age. Younger men with hypogonadism may need fertility preservation strategies before starting treatment.
Older men require cardiovascular risk assessment and prostate monitoring regardless of age. The recent TRAVERSE trial found no increased cardiovascular risk in men aged 45-80, but individual risk factors matter more than age brackets.
If you're considering TRT, get proper evaluation including multiple testosterone measurements, comprehensive health screening, and discussion of risks and benefits specific to your situation. Age is relevant context, but it's not a treatment algorithm.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @dr.yerayraiz's age-specific TRT advice needs context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@dr.yerayraiz's age-specific TRT advice needs context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy requires evaluation of both low testosterone levels (typically under 300 ng/dL on multiple tests) and clinical symptoms, regardless of patient age.
FormBlends verdict
Testosterone replacement therapy requires evaluation of both low testosterone levels (typically under 300 ng/dL on multiple tests) and clinical symptoms, regardless of patient age. The TRAVERSE trial (2018) demonstrated cardiovascular safety in symptomatic hypogonadal men aged 45-80, but treatment decisions should be individualized rather than age-based.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy requires evaluation of both low testosterone levels (typically under 300 ng/dL on multiple tests) and clinical symptoms, regardless of patient age. The TRAVERSE trial (2018) demonstrated cardiovascular safety in symptomatic hypogonadal men aged 45-80, but treatment decisions should be individualized rather than age-based.
- TRT requires both low testosterone levels (under 300 ng/dL) and clinical symptoms, not specific age criteria
- Testosterone declines 1-2% annually after age 40 according to the Baltimore Longitudinal Study, but individual variation is substantial
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- TRT requires both low testosterone levels (under 300 ng/dL) and clinical symptoms, not specific age criteria
- Testosterone declines 1-2% annually after age 40 according to the Baltimore Longitudinal Study, but individual variation is substantial
- The TRAVERSE trial studied men aged 45-80 with confirmed hypogonadism, focusing on symptoms rather than age ranges
- Proper TRT evaluation includes multiple testosterone measurements, LH, FSH, and comprehensive health screening
- Age-based TRT recommendations ignore individual health factors like obesity, sleep apnea, and cardiovascular risk
- Some 70-year-old men maintain higher testosterone than some 30-year-olds according to population studies
- TRT contraindications include prostate cancer history and severe heart failure, which don't correlate with age
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Yeray Raíz · Instagram creator
610.4K views on this video
If you’re from US 🇺🇸 Comment your age below 👇 Follow @dryerayraiz for more health tips #healthytips #spanish #menshealth #mexico #health
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Yeray Raíz, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.